Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
5366 | 1633 | 47.5 | 93% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
422 | 3 | C REACTIVE PROTEIN//STAT3//HAPTOGLOBIN | 28303 |
1051 | 2 | STAT3//GP130//ONCOSTATIN M | 10071 |
5366 | 1 | STAT3//GRIM 19//STAT3 INHIBITOR | 1633 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | STAT3 | authKW | 2125046 | 35% | 20% | 577 |
2 | GRIM 19 | authKW | 485612 | 2% | 84% | 31 |
3 | STAT3 INHIBITOR | authKW | 343686 | 2% | 74% | 25 |
4 | SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 3 | authKW | 215624 | 4% | 18% | 64 |
5 | PSTAT3 | authKW | 99872 | 1% | 23% | 23 |
6 | OPB 31121 | authKW | 93486 | 0% | 100% | 5 |
7 | S3I 201 | authKW | 77903 | 0% | 83% | 5 |
8 | GALIELLALACTONE | authKW | 76341 | 0% | 58% | 7 |
9 | CO EXPRESSION PLASMID | authKW | 74789 | 0% | 100% | 4 |
10 | STAT3 DECOY | authKW | 74789 | 0% | 100% | 4 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 16077 | 51% | 0% | 836 |
2 | Cell Biology | 2343 | 21% | 0% | 338 |
3 | Biochemistry & Molecular Biology | 840 | 22% | 0% | 365 |
4 | Chemistry, Medicinal | 483 | 6% | 0% | 95 |
5 | Medicine, Research & Experimental | 321 | 6% | 0% | 104 |
6 | Genetics & Heredity | 226 | 6% | 0% | 103 |
7 | Pathology | 119 | 3% | 0% | 51 |
8 | Hematology | 64 | 3% | 0% | 45 |
9 | Pharmacology & Pharmacy | 55 | 6% | 0% | 101 |
10 | Immunology | 46 | 5% | 0% | 74 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CHINESE MED PLANTS OURCE LINGNAN | 56092 | 0% | 100% | 3 |
2 | CHILDHOOD CANC | 42366 | 2% | 9% | 26 |
3 | MED PLANTS OURCE SCI ENGN | 42067 | 0% | 75% | 3 |
4 | H LEE MOFFIT CANC INTERDISCIP | 37394 | 0% | 100% | 2 |
5 | NATIONWIDE CHILDRENS HOSP CHILDHOOD | 37394 | 0% | 100% | 2 |
6 | ONCOLMOL ONCOL PROGRAM | 37394 | 0% | 100% | 2 |
7 | UNIT 064 | 37394 | 0% | 100% | 2 |
8 | MOL ONCOL PROGRAM | 32234 | 2% | 6% | 29 |
9 | CANC IMMUNOTHER EUT TUMOR IMMUNOL | 30262 | 1% | 12% | 14 |
10 | COSMETOL PLAST SURG | 24928 | 0% | 67% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MOLECULAR CANCER THERAPEUTICS | 4658 | 2% | 1% | 32 |
2 | ONCOGENE | 4425 | 4% | 0% | 66 |
3 | ONCOTARGET | 3893 | 3% | 0% | 51 |
4 | NEOPLASIA | 3179 | 1% | 1% | 17 |
5 | CANCER RESEARCH | 2385 | 4% | 0% | 72 |
6 | MOLECULAR CANCER | 1502 | 1% | 1% | 12 |
7 | ONCOLOGY REPORTS | 1433 | 2% | 0% | 28 |
8 | INTERNATIONAL JOURNAL OF ONCOLOGY | 1387 | 2% | 0% | 27 |
9 | CURRENT CANCER DRUG TARGETS | 1244 | 0% | 1% | 8 |
10 | CLINICAL CANCER RESEARCH | 1238 | 2% | 0% | 32 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | STAT3 | 2125046 | 35% | 20% | 577 | Search STAT3 | Search STAT3 |
2 | GRIM 19 | 485612 | 2% | 84% | 31 | Search GRIM+19 | Search GRIM+19 |
3 | STAT3 INHIBITOR | 343686 | 2% | 74% | 25 | Search STAT3+INHIBITOR | Search STAT3+INHIBITOR |
4 | SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 3 | 215624 | 4% | 18% | 64 | Search SIGNAL+TRANSDUCER+AND+ACTIVATOR+OF+TRANSCRIPTION+3 | Search SIGNAL+TRANSDUCER+AND+ACTIVATOR+OF+TRANSCRIPTION+3 |
5 | PSTAT3 | 99872 | 1% | 23% | 23 | Search PSTAT3 | Search PSTAT3 |
6 | OPB 31121 | 93486 | 0% | 100% | 5 | Search OPB+31121 | Search OPB+31121 |
7 | S3I 201 | 77903 | 0% | 83% | 5 | Search S3I+201 | Search S3I+201 |
8 | GALIELLALACTONE | 76341 | 0% | 58% | 7 | Search GALIELLALACTONE | Search GALIELLALACTONE |
9 | CO EXPRESSION PLASMID | 74789 | 0% | 100% | 4 | Search CO+EXPRESSION+PLASMID | Search CO+EXPRESSION+PLASMID |
10 | STAT3 DECOY | 74789 | 0% | 100% | 4 | Search STAT3+DECOY | Search STAT3+DECOY |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | WANG, XC , CROWE, PJ , GOLDSTEIN, D , YANG, JL , (2012) STAT3 INHIBITION, A NOVEL APPROACH TO ENHANCING TARGETED THERAPY IN HUMAN CANCERS.INTERNATIONAL JOURNAL OF ONCOLOGY. VOL. 41. ISSUE 4. P. 1181-1191 | 86 | 66% | 54 |
2 | SIVEEN, KS , SIKKA, S , SURANA, R , DAI, XY , ZHANG, JW , KUMAR, AP , TAN, BKH , SETHI, G , BISHAYEE, A , (2014) TARGETING THE STAT3 SIGNALING PATHWAY IN CANCER: ROLE OF SYNTHETIC AND NATURAL INHIBITORS.BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER. VOL. 1845. ISSUE 2. P. 136 -154 | 100 | 36% | 105 |
3 | ZHAO, CG , LI, HM , LIN, HJ , YANG, SL , LIN, JY , LIANG, G , (2016) FEEDBACK ACTIVATION OF STAT3 AS A CANCER DRUG-RESISTANCE MECHANISM.TRENDS IN PHARMACOLOGICAL SCIENCES. VOL. 37. ISSUE 1. P. 47 -61 | 56 | 64% | 8 |
4 | WU, P , WU, D , ZHAO, LF , HUANG, LJ , SHEN, G , HUANG, J , CHAI, Y , (2016) PROGNOSTIC ROLE OF STAT3 IN SOLID TUMORS: A SYSTEMATIC REVIEW AND META-ANALYSIS.ONCOTARGET. VOL. 7. ISSUE 15. P. 19863 -19883 | 64 | 73% | 2 |
5 | SIDDIQUEE, KAZ , TURKSON, J , (2008) STAT3 AS A TARGET FOR INDUCING APOPTOSIS IN SOLID AND HEMATOLOGICAL TUMORS.CELL RESEARCH. VOL. 18. ISSUE 2. P. 254-267 | 88 | 57% | 97 |
6 | MASCIOCCHI, D , GELAIN, A , VILLA, S , MENEGHETTI, F , BARLOCCO, D , (2011) SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 3 (STAT3): A PROMISING TARGET FOR ANTICANCER THERAPY.FUTURE MEDICINAL CHEMISTRY. VOL. 3. ISSUE 5. P. 567 -597 | 93 | 56% | 23 |
7 | DEVARAJAN, E , HUANG, S , (2009) STAT3 AS A CENTRAL REGULATOR OF TUMOR METASTASES.CURRENT MOLECULAR MEDICINE. VOL. 9. ISSUE 5. P. 626-633 | 71 | 65% | 84 |
8 | FURTEK, SL , BACKOS, DS , MATHESON, CJ , REIGAN, P , (2016) STRATEGIES AND APPROACHES OF TARGETING STAT3 FOR CANCER TREATMENT.ACS CHEMICAL BIOLOGY. VOL. 11. ISSUE 2. P. 308 -318 | 51 | 53% | 11 |
9 | FURQAN, M , AKINLEYE, A , MUKHI, N , MITTAL, V , CHEN, YM , LIU, DL , (2013) STAT INHIBITORS FOR CANCER THERAPY.JOURNAL OF HEMATOLOGY & ONCOLOGY. VOL. 6. ISSUE . P. - | 57 | 69% | 39 |
10 | YUE, PB , LOPEZ-TAPIA, F , PALADINO, D , LI, YF , CHEN, CH , NAMANJA, AT , HILLIARD, T , CHEN, Y , TIUS, MA , TURKSON, J , (2016) HYDROXAMIC ACID AND BENZOIC ACID-BASED STAT3 INHIBITORS SUPPRESS HUMAN GLIOMA AND BREAST CANCER PHENOTYPES IN VITRO AND IN VIVO.CANCER RESEARCH. VOL. 76. ISSUE 3. P. 652 -663 | 41 | 93% | 2 |
Classes with closest relation at Level 1 |